Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Yeşim ERALP"'
Autor:
Neslihan Cabioglu, Semen Onder, Gizem Oner, Hüseyin Karatay, Mustafa Tukenmez, Mahmut Muslumanoglu, Abdullah İgci, Yeşim Eralp, Adnan Aydiner, Pınar Saip, Ekrem Yavuz, Vahit Ozmen
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background The expression of immune checkpoint receptors (ICRs) on tumor-infiltrating lymphocytes (TILs) is associated with better response to immunotherapies via immune checkpoint inhibitors. Therefore, we investigated various ICR expressio
Externí odkaz:
https://doaj.org/article/40798d16c81644ad8bc8fe4b8ed49828
Autor:
Atakan Demir, Nil Molinas Mandel, Semra Paydas, Gökhan Demir, Özlem Er, Nazım Serdal Turhal, Sevil Bavbek, Yeşim Eralp, Pınar Mualla Saip, Emine Nilüfer Güler, Adnan Aydıner, Başak Oyan Uluç, Sadettin Kılıçkap, Necdet Üskent, Nuri Karadurmuş, Mehmet Ali Kaplan, Mustafa Teoman Yanmaz, Hacer Demir, Özkan Alan, Taner Korkmaz, Polat Olgun, Özlem Sönmez Uysal, Kadri Altundağ, Şeyda Gündüz, Meral Günaldı, Murat Sarı, İsmail Beypınar, Gül Başaran
Publikováno v:
Balkan Medical Journal, Vol 37, Iss 2, Pp 104-107 (2020)
Background:The synthesis of CDK4/6 inhibitors with endocrine treatment in two series of treatment has been widely accepted as the standard for patients with estrogen receptor-positive metastatic breast cancer. In spite of this, the activity of CDK4/6
Externí odkaz:
https://doaj.org/article/04ceb2349b6c44ffbafb27dfc640256d
Autor:
Çetin Ordu, Kezban Nur Pilancı, Gül Alço, Filiz Elbüken, Ülkühan İner Köksal, Serkan İlgun, Dauren Sarsenov, Ayşe Esra Aydın, Alper Öztürk, Zeynep İyigün Erdoğan, Filiz Ağaçayak, Fatmagül Çubuk, Coşkun Tecimer, Yeşim Eralp, Tomris Duymaz, Fatma Aktepe, Vahit Özmen
Publikováno v:
European Journal of Breast Health, Vol 14, Iss 3, Pp 173-179 (2018)
Objective: In this retrospective study, chemotherapy induced amenorrhea in patients with early stage breast cancer and its effects on survival were investigated.Materials and Methods: Two hundred fifty-two patients received adjuvant chemotherapy with
Externí odkaz:
https://doaj.org/article/456fbf37ff914d6c9dee1064ff92ea33
Autor:
Filiz İzci, Dauren Sarsanov, Zeynep İyigün Erdogan, Ahmet Serkan İlgün, Esra Çelebi, Gül Alço, Nazmiye Kocaman, Çetin Ordu, Alper Öztürk, Tomris Duymaz, Kezban Nur Pilavcı, Filiz Elbüken, Filiz Ağaçayak, Fatma Aktepe, Gizem Ünveren, Gözdem Özdem, Yeşim Eralp, Vahit Özmen
Publikováno v:
European Journal of Breast Health, Vol 14, Iss 2, Pp 105-111 (2018)
Objective:The aim of this study was to investigate the impacts of personality traits, anxiety, depression and hopelessness levels on quality of life in the patients with breast cancer.Materials and methods:The study was performed on 90 patients diagn
Externí odkaz:
https://doaj.org/article/f3175d5f30174493b62f6a5c7f289af2
Autor:
Mine Özkan, Nazmiye Yıldırım, Rian Dişçi, Ahmet Serkan İlgün, Dauren Sarsenov, Gül Alço, Fatma Aktepe, Nesiba Kalyoncu, Filiz İzci, Derya Selamoğlu, Çetin Ordu, Kezban Nur Pilancı, Zeynep İyigün Erdoğan, Yeşim Eralp, Vahit Özmen
Publikováno v:
European Journal of Breast Health, Vol 13, Iss 4, Pp 206-212 (2017)
Objective: The aim of this study was to determine the roles of biopsychosocial risk factors in the development of breast cancer.Materials and methods: This hospital-based case-control study included 491 women with breast cancer (study group) and 512
Externí odkaz:
https://doaj.org/article/20db94b739464c63bd9cd7664d16ce27
Autor:
Eirini Papadopoulou, Nikolaos Tsoulos, Katerina Tsantikidi, Vasiliki Metaxa-Mariatou, Pinelopi Eleftheria Stamou, Athina Kladi-Skandali, Evgenia Kapeni, Georgios Tsaousis, George Pentheroudakis, Dimitrios Petrakis, Dimitra Ioanna Lampropoulou, Gerasimos Aravantinos, Ioannis Varthalitis, George Kesisis, Ioannis Boukovinas, Pavlos Papakotoulas, Nikolaos Katirtzoglou, Elias Athanasiadis, Flora Stavridi, Christos Christodoulou, Anna Koumarianou, Yeşim Eralp, George Nasioulas
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0226853 (2019)
BackgroundAnalysis of circulating tumor nucleic acids in plasma of Non-Small Cell Lung Cancer (NSCLC) patients is the most widespread and documented form of "liquid biopsy" and provides real-time information on the molecular profile of the tumor with
Externí odkaz:
https://doaj.org/article/d6673b33e83343bba170e059cedcb097
Autor:
Zeynep Erdoğan İyigün, Kezban Nur Pilancı, Fatmagül Kuşku Çabuk, Serkan İlgün, Çetin Ordu, Tomris Duymaz, Gül Alço, Filiz Çelebi, Dauren Sarsenov, Filiz İzci, Alper Öztürk, Filiz Ağaçayak, Ülkühan İner Köksal, Fatma Aktepe, Yeşim Eralp, Vahit Özmen
Publikováno v:
European Journal of Breast Health, Vol 12, Iss 3, Pp 119-122 (2016)
Objective: The effect of estrogen on bone mineral density (BMD) and breast cancer has been known for a long time. The aim of this study was to compare of the BMD of patients with breast cancer and healthy individuals, and to investigate the degree of
Externí odkaz:
https://doaj.org/article/b8f92135a661475281e9c693159ee281
Autor:
Yeşim Eralp, Leyla Kılıç, Gül Alço, Gül Başaran, Mutlu Doğan, Dilek Dinçol, Senem Demirci, Fikri İçli, Handan Onur, Pınar Saip, Ayfer Haydaroğlu
Publikováno v:
European Journal of Breast Health, Vol 10, Iss 4, Pp 209-215 (2014)
Objective: Triple negative breast cancer (TNBC) is generally considered as a poorer prognostic subgroup, with propensity for earlier relapse and visceral involvement. The aim of this study is to evaluate the outcome of non-metastatic TNBC patients fr
Externí odkaz:
https://doaj.org/article/48aa9c2f542146b497f2fd6c4342e64d
Autor:
Yeşim Eralp
Publikováno v:
European Journal of Breast Health, Vol 5, Iss 1, Pp 3-8 (2009)
Limited data from small retrospective analyses investigating the role of second- line trastuzumab-based treatment suggests a benefitial effect in terms of time to progression for the management of progressive disease following first-line trastuzumab
Externí odkaz:
https://doaj.org/article/0ce89c64eb334a58b76920de084bdcb5
Autor:
Yen-Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy Azim, Yeşim ERALP, Yoon-Sim Yap, Seock-Ah Im, Julie Rihani, James Bowles, Teresa Delgar Alfaro, Jiwen Wu, Melissa Gao, Khemaies Slimane, Nagi El Saghir
Publikováno v:
Cancer Research. 83:GS1-10
Background: Combination chemotherapy (CT) remains a standard of care in advanced breast cancer (ABC) with aggressive disease features (rapidly progressing or highly symptomatic disease, including life-threatening visceral crisis). To date, no data ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2743f03a1156b7bcc8a4c00772f941ec
https://doi.org/10.1158/1538-7445.sabcs22-gs1-10
https://doi.org/10.1158/1538-7445.sabcs22-gs1-10